0.36
+0.0273(+8.14%)
Currency In USD
Sector
Healthcare
Industry
Biotechnology
Employees
125
First IPO Date
N/A
| Name | Title | Pay | Year Born |
| Mr. Uzi Sofer | Chief Executive Officer & Chairman | 649,000 | 1970 |
| Mr. Ronen Segal | Chief Technology Officer | 269,000 | 1973 |
| Mr. Amnon Gat | Chief Operations Officer | 345,000 | 1975 |
| Mr. Peter M. Melnyk | Chief Commercial Officer | 376,000 | 1962 |
| Dr. Robert B. Den M.D. | Chief Medical Officer & Member of Scientific Advisory Board | 394,000 | 1979 |
| Mr. Raphi Levy | Chief Financial Officer | 420,000 | 1985 |
| Ms. Rebecca Becker | Vice President of legal | 0 | N/A |
| Ms. Yael Zeiger | Corporate Controller | 0 | 1983 |
| Prof. Yona Keisari | Chief Scientific Officer & Member of Scientific Advisory board | 0 | 1947 |
| Prof. Itzhak Kelson | Chief Physics Officer & Member of Scientific Advisory Board | 0 | 1940 |
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, and breast cancers; and preclinical studies for hepatic cell carcinoma, lung, and prostate cancers. The company was founded in 2015 and is headquartered in Jerusalem, Israel.
